IBT
ARNA

International Biotechnology Trust’s Arena Pharmaceuticals Inc ARNA Stock Holding History

International Biotechnology Trust’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-21,000
Closed -$1.95M – 80
2021
Q4 		$1.95M Hold
21,000
– – 0.43% 46
2021
Q3 		$1.25M Hold
21,000
– – 0.3% 51
2021
Q2 		$1.43M Hold
21,000
– – 0.38% 46
2021
Q1 		$1.46M Buy
+21,000
New +$1.62M 0.39% 39
2020
Q4 		– Sell
-16,500
Closed -$1.23M – 55
2020
Q3 		$1.23M Hold
16,500
– – 0.4% 38
2020
Q2 		$1.04M Hold
16,500
– – 0.34% 41
2020
Q1 		$690K Hold
16,500
– – 0.31% 46
2019
Q4 		$749K Hold
16,500
– – 0.27% 54
2019
Q3 		$755K Hold
16,500
– – 0.35% 46
2019
Q2 		$967K Hold
16,500
– – 0.36% 52
2019
Q1 		$740K Buy
+16,500
New +$757K 0.27% 59

International Biotechnology Trust's ARNA Position: Q1 2022 in Review

International Biotechnology Trust sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 21,000 shares — an estimated $1.95M sold.

International Biotechnology Trust first reported a position in ARNA in Q1 2019 and held it in 11 quarters. The position peaked at $1.95M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • International Biotechnology Trust reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • International Biotechnology Trust sold 21,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.95M.
  • International Biotechnology Trust first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 11 quarters.
  • International Biotechnology Trust's Arena Pharmaceuticals Inc position peaked at $1.95M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on International Biotechnology Trust's 13F filing for Q1 2022, filed 20 May 2022.